Skip to main content
. 2023 Feb 7;10:1073025. doi: 10.3389/fmed.2023.1073025

FIGURE 1.

FIGURE 1

(A) The changes in ALT, γ-GTP, TG, HDL-C, FIB-4 index and SWV at baseline and 24 or 48 weeks of treatment with pemafibrate. (B) Normalized ALT as well as AST, γ-GTP, and TG after 24-week treatment with pemafibrate compared to the baseline. (C) The changes in fibrosis stage estimated SWV at baseline and 48 weeks of treatment with pemafibrate. ALT, alanine aminotransferase; γ-GTP, γ-glutamyl transpeptidase; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; FIB-4, fibrosis-4; SWV, shear wave velocity; AST, aspartate aminotransferase.